Frequently it is assumed that concentrations of biochemical arlalytes are similar for serum and plasma, without regard to the anticoagulant. Recently it has been hypothesized that use of certain anticoagulants results in an osmotic redistribution of fluid between blood cells and plasma, causing some dilution of the plasma. We sought to determine the effect of two commonly used anticoagulants, hepann and citrate, on the measured concentrations of 13 clinical-chemical anaytes, including selected trace elements, vitamins, lipids, and proteins. The data demonstrate that hyperosmolar citrate causes a significant dilution of all indices measured. In contrast, heparin had no osmotic effect; concentrations of most of the analytes measured in the hepannized plasma were statistically no different from those measured in the corresponding serum. Therefore, anticoagulants must be chosen carefully, especially if concentrations in plasma and serum are to be compared.
Published reports are conflicting about whether biochemical test results are similar for plasma and serum samples from the same individual or population. For example, in 1968 Foley et at (1) first reported a lower concentration of zinc in citrated plasma than in serum obtained simultaneously from the same subjects. They suggested that this difference could be partly attributed to zinc from platelets contaminating the serum. They also observed that the volume of plasma harvested for citrated whole blood was greater than the volume of serum from noncitrated blood. Although some investigators (2, 3) confirmed the observation that plasma has a lower concentration of zinc than does serum, others (4-7) have observed no difference. Likewise, no consistent difference in the zinc concentration in plasma as compared with that in serum is apparent from literature values.
Makino (5) recently proposed a mechanism for the difference in zinc concentration between serum and plasma, suggesting that "a shift of water from erythrocytes to plasma" was attributable to the greater osmotic pressure of plasma owing to the presence of anticoagulant (citrate) solution. He also indicated that the magnitude of difference between plasma and serum was "dependent on the hematocrit of the blood sample;" i.e., the fewer cells per volume of blood, the less the difference. Makino found no difference between the zinc concentration in plasma or serum when he added heparin at a concentration of about 1100 USP units per liter of whole blood. However, plasma prepared with hyperosmolar heparin solution had a lower zinc concentration. Other investigators (4, (6) (7) (8) also noted that when heparin solution was used as an anticoagulant there were no differences between concentrations of zinc in serum and of the analytes in plasma than in serum. Our purpose was to determine the effect of two commonly used anticoagulants, sodium heparin and sodium citrate, on the concentrations of blood constituents frequently measured in a clinical laboratory. We also compared the osmolality of the plasmas prepared with these two anticoagulants with the osmolality of serum collected from the same individual.
Materials and Methods
The study was approved by the Human Studies Review Committee, Agricultural Research Service, U.S. Department of Agriculture.
After 14 apparently normal volunteers had fasted for 12 h, three specimens of blood were obtained from each in a single venipuncture between 07:00 and 10:00 h by using a "butterfly" infusion set (Minicath#{174}; Deseret Medical Co., Sand, UT 84070). The specimens were drawn in random order so that one type, i.e., serum, was not always the first collected.
Serum. To obtain serum samples, we drew 15 mL of blood into an all-plastic syringe (Starstedt Inc., Princeton, NJ 08540) containing no anticoagulant. After keeping the whole blood at room temperature for 30 mm, we centrifuged it at 2260 x g for 25 mm.
Plasma. We prepared two kinds of plasma samples, adding 0.15 mL of anticoagulant to the barrel of the all-plastic syringe before drawing 15 mL of whole blood into the syringe. The whole blood was kept at room temperature for 30 mm, then centrifuged as for serum. The anticoagulants were either sodium heparin (Sigma Chemical Co., St. Louis, MO 63172), 75 USP units per milliliter of isotonic saline, or sodium Citrate, 300 g/L.
Methods. The analytes assayed and the methods used were as follows: osmolality, freezing point depression: Microosmette5, Instruction manual, Precision Systems, Inc., Sudbury, MA; zinc, flame atomic absorption spectrometry (9); copper, flame atomic absorption spectrometry (10); selenium, graphite furnace atomic absorption spectrometry (11); carotenoids, "high-performance" liquid chromatography (HPLC) (12) 
Statistics.
We evaluated the results by using an analysis of variance based on a randomized block design that treated each subject as a block to control intersubject variation, and Student-Newman-Keuls' multiple comparison test (14) . Means showing a difference with P <0.05 were considered statistically different.
Results
As indicated in Table 1 , the osmolality of the citrated plasma significantly exceeded that of serum (9.2%), whereas that of the heparinized plasma was about the same as that of serum. Moreover, for all of the analytes, measured concentrations were significantly lower in citrated plasma than in the corresponding serum. Except for cholesterol, total protein, and total carotenes, concentrations were not significantly different between serum and heparinized plasma.
However, even for these the concentrations in heparinized plasma were consistently closer to the concentrations in serum than to those in citrated plasma.
DiscussIon
In our laboratory we prefer to use plasma instead of serum for zinc analysis.
Hemolysis of erythrocytes can contaminate the sample with the zinc associated with hemoglobin, which is about 10-fold more concentrated than in serum (1, 15). In addition, serum preparation is less convenient, requiring an interval for clot retraction before centrifugation, during which there may be transfer of zinc to serum from the erthrocytes. Other blood components such as platelets, neutrophils, and lymphocytes (which also have higher zinc concentrations than does serum) may also "leak" zinc into the plasma if left standing for extended periods. Likewise, further hemolysis and (or) contamination may occur if the receding clot is "rimmed."
Previously, the most widely used anticoagulant, heparin, was grossly contaminated with zinc. In 1983, Gervin et al.
(16) noted a wide variation in zinc contamination
of heparin from different sources, ranging from 022 to 3.49 g of zinc per 100 units of heparin. They recommended caution in reporting concentrations of zinc in blood samples that contain sodium heparmn as the anticoagulant.
Because of this contamination problem our laboratory used sodium citrate in previous studies (17) , having identified a lot with little contamination of zinc. However, heparin that is almost free of zinc is currently obtainable, but each lot should be checked before use. 
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43(3#{149}6)t ma: 10 mL of whole blood yielded a mean of 4.7 mL of serum or 5.0 mL of plasma (P <0.001).
It often is assumed that the concentrations of analytes do not differ appreciably in serum and plasma. However, as early as 1935, Schmidt (18) reported that phospholipid concentrations in heparinized plasma were 10 to 12% higher than in oxalated plasma, owing to the alteration in cell and plasma volumes produced by oxalate. The same year, another report (19) confirmed that oxalate alters plasma volumes. Oxalated plasma had significantly lower concentrations of total and free cholesterol as compared with serum or heparinized plasma. In contrast, there was no difference between the cholesterol content of serum and heparinized plasma.
In spite of these earlier studies, serum and oxalated or citrated plasma have been used interchangeably.
In the present study the 13 indices showed an average decrease in citrated plasma concentrations of 7.3% compared with serum, although the volume contributed by the anticoagulants was limited to 1%.
Several studies have compared the concentration of zinc in serum with that in plasma ( Table 2 ), but only one has compared other analytes (total protein and albumin) in addition to zinc (4). Kiilerich et al. (4) found no difference in zinc concentrations between serum and heparinized plasma. They also stated "as expected, the concentration of total protein in plasma is higher than in serum.. . "They gave no explanation of why they "expected" total protein (but apparently not the albumin) to be higher in plasma than serum. However, the differences in total protein concentration were small (less than 1 g/L for normal persons) and of questionable clinical relevance. There was no significant difference between the albumin concentration in serum or heparinized plasma. Nevertheless, our results are in agreement with Kiilerich et al. (4), because heparinized plasma contained slightly more total protein, but not albumin, than did serum (Table 1) .
Although the higher volume of plasma than serum from whole blood reported by Foley et al. (1) has been ascribed as "artefactual due to incomplete expression of serum from the clot" (7) , the decrease of 7.3% for the concentration of 13 indices we measured is similar to the greater yield of plasma reported by Foley et at (1). Shaw et at (7) difference was probably because heparin was used as the anticoagulant instead of citrate. Preliminary data suggest that using ethylenediaininetetraacetate (EDTA) as an anticoagulant also results in a zinc concentration in plasma lower than that in serum (20) .
Those finding no difference in zinc concentration in plasma and serum invariably used heparin as the anticoagulant (Table 2 ). On the other hand, those finding a difference used citrate or oxalate. Our data support Makino's observation concerning zinc concentration and extend it to other analytes: anticoagulants that increase osmolarity cause dilution of plasma.
The differences demonstrated here are statistically significant. They must be kept in mind when normal ranges or "cutoff" values are being established, when groups or populations are being compared, and especially when data collected during longitudinal studies are being interpreted, if concentrations in serum are compared with results for plasma without regard to the type of anticoagulant used.
